AI assistant
Sending…
Solid Biosciences Inc. — Regulatory Filings 2021
Mar 22, 2021
33003_rns_2021-03-22_4b4b8f36-c345-467f-a985-f87ad36c80d4.zip
Regulatory Filings
Open in viewerOpens in your device viewer
CORRESP 1 filename1.htm CORRESP
March 22, 2021
VIA EDGAR SUBMISSION
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, NE
Washington, DC 20549
Attention: Margaret Schwartz
Re: Solid Biosciences Inc.
Registration Statement on Form S-3
File No. 333-254310
Request for Acceleration
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Solid Biosciences Inc. hereby requests acceleration of the effective date of its Registration Statement on Form S-3 (File No. 333-254310), so that it may become effective at 4:30 p.m., Eastern time, on March 24, 2021, or as soon as practicable thereafter.
Very truly yours,
| By: |
|---|
| Ilan Ganot |
| Chief Executive Officer |
More from Solid Biosciences Inc.
Interim / Quarterly Report
2026
May 12
Proxy Solicitation & Information Statement
2026
Apr 23
Board/Management Information
2026
Apr 10
Capital/Financing Update
2026
Mar 19
Annual Report
2026
Mar 19
Major Shareholding Notification
2026
Mar 17
Director's Dealing
2026
Feb 19
Director's Dealing
2026
Feb 19
Director's Dealing
2026
Feb 19
Director's Dealing
2026
Feb 19